National Research Corporation (NRC) Reports Q2 EPS of $0.33
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Burry doubles down on Nebius short after stock surges 34% on earnings
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Home Depot CEO Ted Decker takes medical leave; two executives step in
National Research Corporation Announces Second Quarter 2022 Results
August 2, 2022 5:00 PM EDTLINCOLN, Neb., Aug. 02, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ: NRC) today announced results for the second quarter 2022.
Q2 2022 financial results compared to Q2 2021:
Revenue increased 2% to $37.3 millionOperating income decreased 6% to $11.5 millionIn commenting on recent events, Michael Hays, Chief Executive Officer, said, In the second quarter, our team secured the first official contract for the Human Understanding Program with Novant Health, an integrated health system serving four states... More
